On-treatment higher levels of alpha-fetoprotein and M2BPGi are associated with development of hepatocellular carcinoma during nucleos(t)ide analog therapy in patients with HBV chronic infection.
On-treatment higher levels of alpha-fetoprotein and M2BPGi are associated with development of hepatocellular carcinoma during nucleos(t)ide analog therapy in patients with HBV chronic infection.
复制标题
治疗中较高水平的甲胎蛋白和 M2BPGi 与 HBV 慢性感染患者在核苷（酸）类似物治疗期间发生肝细胞癌有关。
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Watanabe M.
中科院分区：
文献类型：
--
作者：
Murakawa M;Asahina Y;Nakagawa M;Sato A;Miyoshi M;Tsunoda T;Asano Y;Nagata H;Kaneko S;Kawai-Kitahata F;Nitta S;Itsui Y;Azuma S;Kakinuma S;Watanabe M.
